The GenoBioTX cell line service platform is led by multiple experienced experts with years of extensive experience in gene editing. It offers a variety of customized cell line services, including gene knockout, precise knock-in, overexpression, and point mutation. Additionally, the platform provides related cell experimental services such as cell viability testing, ADCC/TDCC assays, mixed lymphocyte reaction (MLR) assays, complement-dependent cytotoxicity (CDC) assays, and antibody-drug conjugate (ADC) bystander assays.
The GenoBioTX molecular detection platform is managed by several experienced technical personnel and senior project management experts. It is equipped with comprehensive and advanced detection instruments and data recording and analysis systems. The platform focuses on target validation, efficient drug screening, and in vitro pharmacological evaluation. It offers a wide range of services, including high-level multiparameter flow cytometry, single/multifactor cell detection, DNA/RNA-related assays, routine blood tests and biochemical analyses, and micro-CT imaging. This allows the platform to meet the diverse R&D needs of clients comprehensively.
GenoBioTX offers a comprehensive range of predefined cytokine combination reagents that can be flexibly selected based on drug mechanisms and experimental objectives. The sensitivity reaches levels as low as 10 pg/mL, and some assays are equipped with ultra-sensitive detection modes, achieving sensitivities of up to 274fg/mL. The detection targets include serum, plasma, tears, aqueous humor, saliva, body cavity wash fluids, cell supernatants, and tissue lysates, covering various species such as mice, rats, monkeys, and humans in the fields of immunology, oncology, neurology, and functional studies.
Please fill in the order form and we will contact you within 2 working days.
